NCT03305445 2023-02-15Nivolumab/Ipilimumab-Primed Immunotransplant for DLBCLIcahn School of Medicine at Mount SinaiPhase 1 Completed6 enrolled
NCT00047164 2016-09-26Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine TherapyNational Institutes of Health Clinical Center (CC)Phase 1 Completed89 enrolled
NCT00060372 2013-03-27Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive CancerNational Cancer Institute (NCI)Phase 1 Completed21 enrolled